Similar results for HOTAIR’s potential to promote resistance to cisplatin or other types of chemotherapy drugs have been obtained for other types of cancer as well, such as hepatocellular carcinoma [187], breast cancer [188], gastric cancer [189], colorectal cancer [173,190], cervical cancer [180], and ovarian cancer [191,192]. This evidence concerns the gene HOTAIR and colorectal cancer.